A Retrospective Comparison of Trastuzumab Plus Cisplatin and Trastuzumab Plus Capecitabine in Elderly HER2-Positive Advanced Gastric Cancer Patients

A combination of trastuzumab and cisplatin or trastuzumab and capecitabine has been confirmed to be effective for treating adverse effects in with HER2-positive advanced gastric cancer (AGC) patients. We retrospectively compared the activity and safety of trastuzumab plus cisplatin (HP) and trastuzu...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Bo, Wu, Jun-Rong, Zhou, Xiao-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
3700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602910/
https://www.ncbi.nlm.nih.gov/pubmed/26313797
http://dx.doi.org/10.1097/MD.0000000000001428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602910/
https://www.ncbi.nlm.nih.gov/pubmed/26313797
http://dx.doi.org/10.1097/MD.0000000000001428

Ejemplares similares